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Abstract: Oral mucosal lesions (OML) can decrease oral health-related quality of life and some have
the potential to become malignant. The aim of the present study was to report the prevalence of OML
in relation to age, sex, and serum cotinine levels in a population with mixed ancestry from South
Africa. This study is part of the Cape Town Vascular and Metabolic Health (VHM) study, conducted
between 2014–2016. Trained dental examiners assessed the oral mucosa for the presence of OML
according to WHO criteria. In total, 1976 individuals were included in the study, being 1496 females
(75.7%) and 480 males (24.3%) with average age of 49.5 years (SD = 15.3). In total, 262 lesions were
detected in 252 participants (overall prevalence of 13%). Males had higher prevalence than females
(14% vs. 9%, p = 0.008). Participants aged 25–34 had the highest prevalence rates (21%). Participants
who had cotinine ≥15 ng/mL had higher prevalence of OML as compared to those with <15 ng/mL
(15% vs. 5%, p < 0.001). Most common lesions were nicotine stomatitis (33%) and leukoplakia (19%).
Age, male sex, and higher cotinine levels were associated with increased prevalence of OML.
Keywords: oral mucosal lesions; non-communicable diseases; oral health
1. Introduction
Oral health plays a fundamental role in the overall health and well-being. Lack of attention to
oral health is a serious concern, given that oral diseases are remarkably prevalent, affecting around
3.5 billion people around the world [1]. Dental caries, periodontal disease, tooth loss, oral mucosal
lesions (OML), and oropharyngeal cancers constitute the most challenging oral conditions in terms of
public health [2].
Oral lesions can decrease oral health-related quality of life due local irritation, discomfort, pain,
and the potential to interfere with mastication, speech, swallowing, and oral hygiene [3]. The etiology
of OML is not completely understood, however, a number of modifiable risk factors are shared between
oral diseases and the leading non-communicable diseases (NCDs): Cardiovascular disease, cancer,
respiratory diseases, and diabetes [4,5]. The shared risk factors include social determinants of health,
exposure to tobacco, unhealthy diet and alcohol consumption. There is a consistent social gradient
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between the prevalence and severity of oral diseases and socioeconomic status [1,2]. NCDs, that are
associated with social determinants of health and oral diseases, contribute to inequity across and
within countries [1].
Cotinine constitutes the main nicotine metabolite in tobacco products and it presents a longer
half-life when compared to nicotine (10–30 h versus 30 min, respectively), and is considered a
dependable biomarker for tobacco exposure [6]. Studies suggest that serum cotinine levels, ranging
from 10 to 20 ng/mL, are compatible with active smoking and, in the present study, 15 ng/mL was
chosen as the cut-off value to separate smokers from non-smokers, according to previous studies [7,8].
While, most OML are benign and self-limiting, some can be potentially malignant. Leukoplakia,
erythroplakia, and oral sub-mucous fibrosis are the most common pre-cancerous lesions [9].
The importance of early detection of pre-cancerous lesions cannot be underestimated, as it is the most
important factor affecting morbidity and survival rates [10].
Epidemiological studies on oral lesions provide crucial information on their prevalence, extent and
severity, providing the foundation for oral health policies [11]. There is a scarcity of epidemiological
studies on OML in Africa. In South Africa, there are few reports on oral lesions and pre-cancerous
lesions. In a study on oral cancer in South Africa, the prevalence of oral squamous cell carcinoma was
reported to be higher in males with mixed ethnic background [12].
To the best of our knowledge, there are no studies evaluating serum cotinine levels in relation to
oral health status in the country. Cotinine is the main metabolite of nicotine, which is an addictive
chemical found in tobacco products [13]. Due to its long half-life, serum cotinine has been used as a
biomarker for exposure to tobacco smoking [8]. The aim of the present cross-sectional epidemiological
study was to report the prevalence of oral mucosal lesions in relation to age, sex, and serum cotinine
levels in a population sample from the Belville South area in South Africa.
2. Materials and Methods
2.1. The Sample
This cross-sectional study was conducted as part of the Cape Town Vascular and Metabolic
Health (VHM) study, conducted from 2014 to 2016 in South Africa, as described previously [14].
The Ethics Committee of the Faculty of Health and Wellness Sciences of the Cape Peninsula University
of Technology (N14/01/003a) approved the study, which was conducted according to the Declaration of
Helsinki. The target population was adults living in the Bellville South area, a community characterized
by mixed ethnic ancestry as well as low-socioeconomic status. A consecutive sampling technique
was used to recruit potential participants according to the following inclusion criteria: Individuals of
mixed ancestry (defined in accordance to the South African Population Registration Act No. 30 of
1950, repealed in 1991), living in the Bellville area of the Western Cape Province, South Africa, with
a minimum age of 18 years who signed the informed consent [15]. The exclusion criteria included
individuals requiring prophylactic antibiotics, undergoing renal dialysis, with intellectual disabilities,
with cancer, younger than 18 years, pregnant women, and those who were too ill or unable to sign
the consent.
2.2. Clinical Examination
Trained and calibrated dental examiners comprehensively assessed the oral mucosa in each
participant. The oral examination was undertaken using a portable dental chair, a portable overhead
LED light, dental mirrors, and the handle of a periodontal probe for tissue retraction. All sections of
the oral cavity were inspected systematically for any variation from normal in the following sequence,
according to the criteria from the WHO: (1) Upper and lower labial mucosa and labial sulci, (2) buccal
mucosa, (3) tongue, (4) floor of the mouth, (5) palate, and (6) gingiva and alveolar [16] The presence
of Malignant tumor (oral cancer), leukoplakia, lichen planus, ulceration, acute necrotizing ulcerative
gingivitis (ANUG), candidiasis, abscess and other condition was recorded for each of the following
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locations: Vermillion border, commissures, lips, sulci, buccal mucosa, floor of the mouth, tongue, soft
and hard palate, gingiva, and alveolar ridge.
2.3. Serum Cotinine
In the present study, 15 ng/mL was used as the cut-off value to differentiate smokers from
non-smokers, based on previous studies [6–8]. A fasting blood sample was collected and transported
to an accredited laboratory within 6 h of collection for processing. A chemiluminescent assay was used
after blood samples had been processed, in order to measure serum cotinine levels (Immulite 1000,
Siemens), as described previously [15].
2.4. Statistical Analysis
Data were analyzed through the statistical package Stata 15.1 (StataCorp, LLP, College Station, TS,
USA). Presence of oral mucosal lesions was presented as percentage prevalence. Age was categorized
into groups (≤24, 25–34, 35–44, 45–54, 55–64, and≥65 years), as well as serum cotinine levels (<15 ng/mL
and ≥15 ng/mL). The Chi-square test and the Fisher test were used to compare the proportion of oral
lesions in relation to sex, age group, and cotinine categories. A logistic regression was carried out to
determine the probability of having at least one lesion of any type given sex, age group, and cotinine
levels. A p-value of 0.05 and below was considered statistically significant.
3. Results
3.1. Total Prevalence
In total, 1976 individuals were included in the study, from which 1496 were females (75.7%) and
480 were males (24.3%). The sample had an average age of 49.5 years (SD = 15.3), ranging from 18 to
91 years. The average age was 47.3 for males and 50.2 years for females.
A total of 262 lesions were detected in 252 participants (overall prevalence of 13%, Figure 1). OML
were associated with sex, with males presenting higher prevalence of lesions than females (14% versus
9%, respectively, p = 0.003, Figure 1).
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nicotine stomatitis (66.4%); in the alveolar ridge/gingiva it was leukoplakia (35.8%); and in the buccal
mucosa was abscess (78.9%).Int. J. Environ. Res. Public Health 2020, 17, 1065 4 of 10 
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Variable Odds Ratio 95% Confidence Interval p-Value
Gender
Male Reference
Female 0.395 0.297–0.525 0.000 *
Age group (years)
≤24 Reference
2–34 1.125 0.65–1.941 0.671
3–44 1.390 0.81–2.378 0.230
4–54 0.607 0.35–1.041 0.070
5–64 0.247 0.13–0.460 0.000 *
≥65 0.171 0.08–0.358 0. 0 *
Cotinine Levels
<15 ng/mL Reference
≥15 ng/mL 2.938 2.16–3.987 0.000 *
* p-Value < 0.05 (Statistically significant at 5% level of significance).
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3.2. Oral Mucosal Lesions (OML) Lesion Types
Nicotine stomatitis was the most prevalent lesion (33% of all lesions, n = 87, Table 2), followed by
leukoplakia (19%, n = 48), abscess (14%, n = 35), candidiasis (6%, n = 12), ulcerations (3%, n = 9), and
ANUG (3%, n = 7). In total, 21% of the oral lesions were classified as ‘other conditions’.
Table 2. Distribution (% and count) of different oral mucosal lesions according to sex and age group.
Nicotine
Stomatitis Leukoplakia Abscess Candidiasis Ulceration ANUG Other
Sex
Male 26% (23) 44% (21) 34% (12) 25% (3) 44% (4) 29% (2) 24% (13)
Female 74% (64) 56% (27) 66% (23) 75% (9) 56% (5) 71% (3) 76% (41)
p-Value 0.63 0.001 0.164 1.00 0.233 0.680 0.970
Age group
<24 9% (8) 8% (4) 20% (7) 8% (1) 22% (2) 14% (1) 2% (1)
25–34 30% (26) 35% (17) 26% (9) 24% (3) 34% (3) 30% (2) 22% (12)
35–44 25% (22) 19% (9) 17% (6) 33% (4) 22% (2) 14% (1) 31% (17)
45–54 28% (24) 25% (12) 28% (10) 25% (3) 11% (1) 14% (1) 20% (11)
55–64 2% (2) 11% (5) 9% (3) 8% (1) 11% (1) 14% (1) 16% (8)
>65 6% (5) 2% (1) 0 0 0 14% (1) 9% (5)
p-Value <0.001 <0.001 <0.001 0.129 0.068 0.704 0.002
Total 33% (87) 19% (48) 14% (35) 7% (12) 3% (9) 3% (7) 21% (54)
ANUG: acute necrotizing ulcerative gingivitis.
3.3. Nicotine Stomatitis
The overall prevalence of nicotine stomatitis was 4.4%. Sex was not associated with prevalence of
this lesion (p = 0.63, Table 2). There was an association between age group and nicotine stomatitis
(p < 0.001) and the age groups with the highest prevalence were 25–34 years (30%), 35–44 years (25%),
and 45–54 years (28%). Most nicotine stomatitis lesions were located in the palate (91%, n = 79),
followed by alveolar ridge/gingiva (5%, n = 4), lips (2%, n = 2), sulci (1%, n = 1) and tongue (1%, n = 1).
Cotinine categories were associated with prevalence of nicotine stomatitis (p < 0.001, Figure 3).
Regarding distribution of nicotine stomatitis by cotinine levels, participants with level 15 ng/mL and
above had about three-time more lesions than participants with serum cotinine ≥15 ng/mL. This
association was statistically significant for males (p = 0.03) and females (p < 0.001), as well as for the
age groups 25–34 (p = 0.009), 35–44 (p = 0.002), and 45–54 (p = 0.001, Figure 3).
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3.4. Leukoplakia
Oral leukoplakia was more prevalent in females (56%) as compared to males (44%, p = 0.001,
Table 2), with total prevalence of 2.4%. There was an association between age group and prevalence
of oral leukoplakia (p < 0.001), with participants aged 25–34 presenting the highest prevalence (35%,
Figure 4).
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Figure 4. Distribution of leukoplakia according to serum cotinine categories (<15 ng/mL and≥15 ng/mL)
in relation to sex (p = 0.007 for females), age group (p = 0.01 for 35–44), and total (p < 0.001).
Tongue (37.3%, n = 19) and alveolar ridge (37.3%, n = 19) were the most common locations for
leukoplakia lesions, followed by palate (9.8%, n = 5), sulci (5.9%, n = 3), lips (5.9%, n = 3), and buccal
mucosa (3.9%, n = 2).
Cotinine categories were associated with the distribution of leukoplakia (p < 0.001, Figure 4).
Female participants with serum cotinine 15 ng/mL and above had higher prevalence of leukoplakia
when compared to females with cotinine levels below 15 ng/mL (p = 0.007). This association was
also statistically significant for the age group 35–44, with all leukoplakia lesions being present in
participants with cotinine levels ≥15 ng/mL (p = 0.01).
3.5. Candidiasis, Abscess, Ulceration, Acute Necrotizing Ulcerative Gingivitis (ANUG), and other Conditions
The overall prevalence of candidiasis was 6% and it was not associated with sex or age group
(Table 2). Candida lesions were observed in the palate (63%, n = 10), alveolar ridges/gingiva (25%,
n = 4), tongue (6%, n = 1) and sulci (6%, n = 1). The prevalence of candidiasis was higher in subjects
who presented serum cotinine levels 15 ng/mL and above, when compared to those with cotinine level
below 15 ng/mL (83% versus 17%, respectively, p = 0.02).
Prevalence of abscess (15%) was not associated with sex or cotinine levels. It was associated with
age group (p < 0.001), with participants aged 45-54 presenting the highest prevalence (29%). In terms
of location, 83% (n = 30) of the abscesses were located in the alveolar ridge/gingiva, followed by 8%
(n = 3) in the buccal mucosa, 6% (n = 2) in the palate and 3% (n = 1) in the commissure.
The prevalence of ulceration (3%) and ANUG (3%) were not associated with sex, age group, or
cotinine categories. Ulcerations were mostly observed at the buccal mucosa (56%, n = 5), sulci (22%,
n = 2), floor of the mouth (11%, n = 1), and tongue (11%, n = 1).
Lesions classified as “other conditions” were not associated with sex or cotinine levels. They were
associated with age group (p = 0.002), with the highest prevalence in the 35–44 age group (31%).
The palate was the most frequent location (41%, n = 23), followed by alveolar ridge/gingiva (29%,
n = 16), tongue (23%, n = 13), commissure (4%, n = 2), lips (2%, n = 1), and sulci (2%, n = 1).
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4. Discussion
To our knowledge, this is the first epidemiological study to report on the prevalence of oral
mucosal lesions in South Africa since the last national survey 30 years ago. Results from our study
show total prevalence of OML of 13%, with males presenting higher prevalence than females. Ages
between 25–34 years and serum cotinine levels that indicate smoking (≥15 ng/mL) were associated
with higher prevalence of OML. Nicotine stomatitis was the most prevalent condition, corresponding
to one-third of all identified lesions.
To our knowledge, this is the first epidemiological population study to present the prevalence of
oral mucosal lesions in this South African sample of adults with mixed ethnic background. Comparison
with previous studies is not possible as data are only available for HIV-related oral lesions [17–20],
lesions in children [21], and in pregnant women [22].
A variety of studies from other countries report prevalence of OML, ranging from 2 to 80% [23–27].
Some studies include normal variations of the oral mucosa, such as hairy tongue, fissured tongue,
and bone exostosis, hence, there are differences in the definition of oral lesions can partially explain
the high rates reported by some authors [28]. The prevalence of oral lesions in South Africa (13%) is
comparable to other upper middle income countries, such as Turkey (15.5%) [26], China (9.5%) [24],
and Malaysia (9.7%) [28], and somewhat lower than the prevalence of oral lesions in Brazil (23,3%) [29].
The higher prevalence of oral lesions in male participants could be explained by higher serum
cotinine levels. In the literature, there are studies reporting no association of OML with sex [29,30], as
well as studies reporting higher prevalence of oral lesions in males [5,26] and females [31]. Besides
exposure to tobacco, alcohol consumption is another risk factor for OML and other NCDs. Studies
have reported high risk for harmful drinking among South Africans with mixed ethnic background
from underprivileged communities [32,33]. In future studies on NCDs and oral diseases, information
on drinking habits can be useful when planning strategies to address common risk factors to NCDs.
Age has been associated with an increased prevalence of OML [5,34,35]. However, this was not
the case in the studied sample, as most lesions were observed in participants aged 25 to 34 years, with
decreased prevalence for participants 55 and older. A high exposure to tobacco, early in adulthood in
the current sample, and the potential exposure to secondary smoking within each household included
in the study, might predispose to oral lesions earlier in life [36].
Almost one fifth of oral lesions observed in this study were identified as leukoplakia, and the
estimated risk for malignant transformation for these lesions range from 0.13 to 34% [37]. Early
screening and diagnosis is still the best approach to decreasing morbidity and mortality associated with
oral cancer [38], which further highlights the need for oral health programs that promote screening,
diagnosis, and treatment of lesions in the oral cavity.
Smoking is a strong risk factor for NCDs, oral cancer, and OML [39], In the current study, there
was an association between the prevalence of OML and increased cotinine levels, particularly for
leukoplakia, which is potentially pre-cancerous, and for nicotine stomatitis, which is directly related to
exposure to tobacco. Creation of robust tobacco cessation programs needs to become a priority for this
disadvantaged population group in terms of prevention and management of oral diseases and other
NCDs [40].
Limitations of the Study
The high prevalence of non-diagnosed lesions can point to a lack of precise diagnostic criteria.
Examiners were not capable of differentiating between 21% of the mucosal changes encountered.
Future studies should include diagnostic tests and use digital resources to facilitate the interaction
with a specialist in oral medicine during clinical examinations for diagnostic accuracy. The clinical
examination took place during weekdays, which have resulted in selection bias, due to exclusion of
males who worked.
Although, patients with leukoplakia were referred to an appropriate health-care facility for further
laboratory investigations to confirm the initial clinical diagnosis, and they were not followed-up.
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Hence, the initial tentative diagnosis was not confirmed through biopsy nor other diagnostic tests.
An epidemiological study from Japan reported mass screening for leukoplakia in 3131 participants.
The authors reported a positive predictive value of 0.73 and false positive ratio of 0.27 for diagnosing
oral leukoplakia during the primary mass screening, which can be extrapolated to the results from the
current study [41].
5. Conclusions
This is the first study providing epidemiological data on oral lesions and cotinine levels for a
population sample of mixed ethnic background from South Africa. Males, participants younger than
54 years, and higher cotinine levels were associated with a higher prevalence of lesions. The two
most common lesions were nicotine stomatitis and leukoplakia, the latter has the potential to undergo
malignant transformation. Programs aimed at reducing exposure to tobacco should be an integral part
of reducing the burden of NCDs in this population group. Early screening and diagnosis of mucosal
lesions should be a priority in primary care settings, as it can decrease morbidity and mortality related
to oral cancer.
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